A2 Refereed review article in a scientific journal
Epitranscriptomic control of telomere maintenance
Authors: Pashay Ahi, Ehsan; Ghasemishahrestani, Zeinab
Publication year: 2026
Journal: Molecular Biology Reports
Article number: 513
Volume: 53
ISSN: 0301-4851
eISSN: 1573-4978
DOI: https://doi.org/10.1007/s11033-026-11699-w
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Partially Open Access publication channel
Web address : https://doi.org/10.1007/s11033-026-11699-w
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/522855690
Self-archived copy's licence: CC BY
Self-archived copy's version: Publisher`s PDF
Telomere maintenance has been portrayed primarily as a problem of DNA–protein architecture and chromatin control, yet a complementary layer has been revealed at the level of RNA chemistry. In this Review, RNA modifications and their writer–reader–eraser and RNA-editing systems are integrated into a framework for chromosome-end homeostasis. Epitranscriptomic regulation of the telomerase ribonucleoprotein is examined, and assembly, activity, and recruitment are shown to be reshaped by chemical marks on TERC, specialized RNA capping, and processing pathways. Telomeric transcripts, particularly TERRA, are discussed as modified substrates whose stability, trafficking, and propensity for telomeric RNA: DNA hybrid formation can be tuned by RNA marks and their readers. Downstream consequences for replication stress, DNA damage signaling, and recombination-driven alternative lengthening of telomeres are summarized, together with emerging examples in which modification of telomere-factor mRNAs has been linked to rewiring of maintenance networks. Across these themes, links to telomeropathies, aging-associated inflammation, environmental stressors, and cancer are collated to connect mechanism to phenotype. Experimental bottlenecks and opportunities—site-resolved mapping, locus-targeted editing, and pharmacologic modulation of RNA-modifying enzymes—are outlined as routes toward causal models and therapeutic utilization.
Downloadable publication This is an electronic reprint of the original article. |
Funding information in the publication:
Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital).